Stem Cell Therapeutic and Research Reauthorization Act of 2025

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5160 Introduced in House (IH)]

<DOC>

119th CONGRESS
  1st Session
                                H. R. 5160

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
                          for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 4, 2025

 Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Bilirakis, Ms.
  Pingree, Ms. Tenney, and Mr. Mfume) introduced the following bill;
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stem Cell Therapeutic and Research
Reauthorization Act of 2025''.

SEC. 2. REAUTHORIZATION OF THE C.W. BILL YOUNG CELL TRANSPLANTATION
              PROGRAM.

    Section 379B of the Public Health Service Act (42 U.S.C. 274m) is
amended--
            (1) by striking ``appropriated $31,009,000'' and inserting
        the following: ``appropriated--
            ``(1) $31,009,000'';
            (2) in paragraph (1), as so inserted, by striking the
        period at the end and inserting ``; and''; and
            (3) by adding at the end the following:
            ``(2) $33,009,000 for each of fiscal years 2027 through
        2031.''.

SEC. 3. CORD BLOOD INVENTORY.

    Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005
(42 U.S.C. 274k note) is amended by striking ``2026'' and inserting
``2031''.
                                 <all>